Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 25;12:4981–4990. doi: 10.2147/CMAR.S251264

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The effects of miR-181a-5p on the cisplatin sensitivity in EAC cells. (A) The expressions of miR-181a-5p were measured in OE19 and OE19/CDDP by qRT-PCR. (B) OE19/CDDP cells were transfected with miR-181a-5p mimic and miR-NC, OE19 cells were transfected with anti-miR-181a-5p and anti-NC and the transfection efficiency was detected by qRT-PCR. After 24 hours of transfection, cisplatin was treated for 48 hours at different concentration. Cell viability (C and D) and apoptosis (E) were detected using CCK-8 assay or flow cytometry, respectively. *P<0.05.